Intriguingly, ezrin regulates the expression of angiogenic factors in both macrophages as well as tumor cells, as ezrin knockdown in breast cancer cells reduces the macrophage expression of VEGFA and MMP9 mRNAs [56,57]. Here, MMP9 is linked to breast cancer.